In the News AACR 2026 Selects ORGANOPlus’ Microbiome Oncology Candidate OP820 for Poster Presentation Mar 19, 2026 AACR 2026 selected OP820, a mucin-binding microbiome oncology candidate identified using ORGANOPlus’ villus-mimicking organ-on-a-chip platform, demonstrating translational efficacy across both in vitro and in vivo models. PreviousORGANOPlus established its first European entity in CopenhagenNextORGANOPlus Showcases Oncology Validation Platform at BIO-Europe Spring 2026 Back to list
